Patents by Inventor Amina Odidi

Amina Odidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6479075
    Abstract: This invention in general relates to novel pharmaceutical compositions for acid labile substances as well as for methods of making such. Specifically, the invention provides a pharmaceutical composition comprising about 1 to 75% by weight acid labile compound, up to about 5% by weight disintegrant, at least one protector coat layer used to separate and protect the acid labile substance from acid reacting groups and gastric juice, and at least one enteric coat layer which surrounds the protector coating layer and ensures delivery of over 80% the acid labile substance to the small intestine.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: November 12, 2002
    Inventors: Isa Odidi, Amina Odidi
  • Publication number: 20020051817
    Abstract: The present invention provides a novel sustained release composition and method for making such a composition of diclofenac and its pharmaceutically acceptable salts. The composition of the present invention provides a sustained release formulation of diclofenac and pharmaceutically acceptable salts thereof which is suitable for once daily administration and provides controlled and long lasting in vivo release. The composition comprises: (a) about 5-25% by weight of hydroxyethyl cellulose; (b) about 5-75% by weight of lactose; (c) about 0-3% by weight of silicone dioxide; (d) about 0.5-5% by weight of PVP; (e) about <3% by weight of talc; and f) about <3% by weight of magnesium stearate.
    Type: Application
    Filed: August 31, 2001
    Publication date: May 2, 2002
    Inventors: Isa Odidi, Amina Odidi
  • Patent number: 6312724
    Abstract: The present invention provides a novel sustained release composition and method for making such a composition of diclofenac and its pharmaceutically acceptable salts. The composition of the present invention provides a sustained release formulation of diclofenac and pharmaceutically acceptable salts thereof which is suitable for once daily administration and provides controlled and long lasting in vivo release. The composition comprises: (a) about 5-25% by weight of hydroxyethyl cellulose; (b) about 5-75% by weight of lactose; (c) about 0-3% by weight of silicone dioxide; (d) about 0.5-5% by weight of PVP; (e) about <3% by weight of talc; and f) about <3% by weight of magnesium stearate.
    Type: Grant
    Filed: April 3, 1998
    Date of Patent: November 6, 2001
    Inventors: Isa Odidi, Amina Odidi
  • Patent number: 6296876
    Abstract: This invention in general relates to novel pharmaceutical compositions for acid labile substances as well as for methods of making such. Specifically, the invention provides a pharmaceutical composition comprising about 1 to 75% by weight acid labile compound, up to about 5% by weight disintegrant, at least one protector coat layer used to separate and protect the acid labile substance from acid reacting groups and gastric juice, and at least one enteric coat layer which surrounds the protector coating layer and ensures delivery of over 80% the acid labile substance to the small intestine.
    Type: Grant
    Filed: October 5, 1998
    Date of Patent: October 2, 2001
    Inventors: Isa Odidi, Amina Odidi